Chi-Yin Liao

Articles by Chi-Yin Liao

90 Real-World ESR1 Mutation and Testing Rates in Patients With ER+/HER2– Metastatic Breast Cancer

ByChi-Yin Liao,Neha Bansal,Jincy John,Manali Bhave, MD,Francois Clement Bidard,Tyler Marquart,Aarti Chawla,Lindsay A. Williams

May 26th 2026

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Camizestrant for ESR1-Mutated HR+/HER2– Advanced Breast Cancer

How Might WCLC 2026 Clarify the Evolving Role of APPs in Lung Cancer?

How Is AI Advancing Tumor Boards, Care Coordination, and Treatment Planning?

Saturated Fat Intake Linked to Greater Mortality in Nonmetastatic Prostate Cancer

Can Ropeginterferon Elicit Disease Modification in Essential Thrombocythemia?